Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
Recruiting · NCT07189260 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital Bispebjerg and Frederiksberg
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this clinical trial is to investigate whether pre- and postoperative treatment with systematic PEP therapy can prevent hospital-acquired pneumonia in patients with hip frac-ture. It will also learn about the barriers regarding PEP therapy in this group of patients. * Does pre- and postoperative treatment with systematic PEP therapy prevent hospital-acquired pneumonia in patients with hip fracture? * Which barriers do participants have regarding PEP therapy in this group of patients? Researchers will compare systematic PEP therapy to no intervention besides standard treat-ment to see if systematic therapy with PEP can prevent hospital-acquired pneumonia. Participants will: * Receive systematic PEP therapy during hospitalization or no intervention besides standard treatment * Register the PEP therapy four times daily on a paper checklist. Failure to perform the treatment and the reason must also be documented on the checklist.
Who can take part
Inclusion criteria
- Hip fracture regardless of age
- Cognitively well-functioning
- Able to understand the study and give informed consent
- Able to speak and understand Danish
- Resident of Region Hovedstaden or Region Sjælland
Exclusion criteria
- Cognitively impaired
- Unable to understand the study and give informed consent
- Pneumonia upon admission
- Delirium upon admission
- Pneumothorax
- For patients with e.g. dementia or brain injury, the ability to give informed consent will be assessed individually.
Where it is running
2 locations listed.
- Bispebjerg & Frederiksberg Hospital - Copenhagen, Denmark
- Herlev & Gentofte Hospital - Herlev, Denmark